Pfizer Inc
Adobe CEO Shantanu Narayen says he will step down after company installs successor
Adobe said CEO Shantanu Narayen will step down after a successor has been appointed, and he will remain as the design software company’s chair. Shares tumbled 7% in extended trading. Narayen joined Adobe in 1988 as a vice president and general manager, and he became CEO in 2007. Under Narayen, Adobe pushed from software licenses […]
Read More
Iran war: Israel’s president Herzog calls ‘cost’ for business the price for Middle East peace
Israeli President Isaac Herzog visits the site of an Iranian strike in Beit Shemesh, Israel, March 2, 2026. Alexi J. Rosenfeld | Getty Images Israeli President Isaac Herzog told a group of U.S. business leaders at the Yale CEO caucus meeting on Tuesday that he understands their concerns about the costs of the war against […]
Read More
FDA approves leucovorin as first drug for rare genetic disorder, after touting it as autism treatment
FILE PHOTO: The headquarters of the U.S. Food and Drug Administration (FDA) is seen in Silver Spring, Maryland November 4, 2009. Jason Reed | Reuters The Food and Drug Administration on Tuesday approved a decades-old prescription vitamin called leucovorin as the first treatment for a rare genetic disorder in certain adults and children. The move […]
Read More
Oil prices top $100, FDA leadership change, the wellness boom and more in Morning Squawk
This is CNBC’s Morning Squawk newsletter. Subscribe here to receive future editions in your inbox. Good morning. If you’re getting on a plane soon, consider this a public service announcement that you may want to give yourself extra time for security lines. Stock futures are tanking this morning following a losing week on Wall Street. Here are […]
Read More
FDA vaccine head will step down in April after string of controversial decisions
The logo for the Food and Drug Administration is seen ahead of a news conference at the Health and Human Services Headquarters in Washington, DC on April 22, 2025. Nathan Posner | Anadolu | Getty Images A key U.S. Food and Drug Administration official who oversees vaccines and biotech treatments will step down from the […]
Read More
AI disruption didn’t show up in Salesforce results. But the fears are hard to shake
Salesforce on Wednesday evening delivered better-than-expected 2026 fourth-quarter results as its Agentforce artificial intelligence platform became increasingly embedded across the business. However, the stock dropped in after-hours trading as investors remained anxious about the potential of AI disrupting traditional enterprise software companies. Revenue in the quarter ended Jan. 31 rose 12% year over year to […]
Read More
These 4 charts show the scale of Novo Nordisk’s woes
Novo Nordisk was the first company to make a GLP-1 drug for weight loss and became Europe’s most valuable company. But its troubles are stacking up and today the stock trades at just a quarter of what it did at its peak less than two years ago. Pricing pressure, fierce competition, and pipeline setbacks have […]
Read More
Russia’s war on Ukraine puts women off having children — and that could spell economic disaster
A woman carries a baby as she reacts after evacuating from Russian troop-occupied Kupiansk town in a bus convoy, amid Russia’s attack on Ukraine, on the outskirts of Kharkiv, Ukraine May 30, 2022. Picture taken May 30, 2022. Ivan Alvarado | Reuters Four years of war between Russia and Ukraine are beginning to take their […]
Read More
Jim Cramer’s top 10 things to watch in the stock market Friday
My top 10 things to watch Friday, Feb. 20 1. Blue Owl Capital’s loan sales, part of a plan to return capital to investors, has observers bringing out “canary in the coal mine” warnings again. While many private credit loans seem mismarked, this situation doesn’t appear tragic in nature. 2. Stock futures were lower after […]
Read More
Walmart earnings, Fed meeting minutes, Zuckerberg’s testimony and more in Morning Squawk
This is CNBC’s Morning Squawk newsletter. Subscribe here to receive future editions in your inbox. Happy Thursday. My spin class soundtrack of mainly Kesha’s music last night was more evidence that the 2016 aesthetic is back. Stock futures are lower this morning. The three major indexes are coming off a winning session. Here are five key things […]
Read More